Gelonghui April 22 | Hebang Biotech (603077.SH) fell to a halt, reaching a new low of 2.13 yuan since August 2021, with a market value of 18.9 billion yuan. According to news, the company achieved operating income of 1,999 billion yuan in the first quarter, a year-on-year decrease of 16.51%, and realized net profit of 29.79 million yuan, a year-on-year decrease of 92.49%. Net cash flow from operating activities was 433 million yuan, which turned negative year-on-year. The balance ratio was 23.26%, up 7.17 percentage points from the previous year.
A股异动 | 和邦生物跌停 首季净利同比下降92%
Changes in A-shares | Hebang Biotech's net profit fell 92% year-on-year in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated